Pharmala Biotech 주식 가격. MDMA - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
캐나다
CSE
Pharmala Biotech Holdings Inc (MDMA) 시세

Pharmala Biotech Holdings Inc (MDMA)

0.22

0.005

( 2.33% )

업데이트: 00:25:55

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

가격

0.22

매수가

0.215

매도가

0.225

거래량

8,318

0.21 일간 변동폭 0.23

0.065 52주 범위 0.34

전일 종가

0.215

개장가

0.21

최근 거래 시간

마지막 거래 시간

00:25:53

평균 볼륨(3m)

270,476

재정 규모

-

VWAP

-

No news to show yet.

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-0.04	-15.3846153846	0.26	0.275	0.21	112256	0.23587441	CS
4	-0.01	-4.34782608696	0.23	0.29	0.195	199275	0.24000951	CS
12	-0.075	-25.4237288136	0.295	0.33	0.195	270476	0.26593491	CS
26	0.115	109.523809524	0.105	0.34	0.07	320369	0.22921867	CS
52	0.015	7.31707317073	0.205	0.34	0.065	332577	0.19116819	CS
156	0.155	238.461538462	0.065	0.54	0.02	555108	0.19624008	CS
260	-0.22	-50	0.44	0.54	0.02	553658	0.19230497	CS

MDMA - Frequently Asked Questions (FAQ)

What is the current Pharmala Biotech share price?

The current share price of Pharmala Biotech is $ 0.22

What is the 1 year trading range for Pharmala Biotech share price?

Pharmala Biotech has traded in the range of $ 0.065 to $ 0.34 during the past year

가장 활성
% 상승자
% 패자

기호	가격	볼륨
FNQFineqia International Inc	$ 0.01 (100.00%)	59.4k
CATCAT Strategic Metals Corporation	$ 0.01 (100.00%)	19k
NTNewterra Resources Inc	$ 0.07 (75.00%)	1,000
WINCommon Stock	$ 0.015 (50.00%)	1.52M
LCRLancaster Resources Inc	$ 0.015 (50.00%)	65k
KVMKingsview Minerals Ltd	$ 0.005 (-66.67%)	33k
LTHMChampion Electric Metals Inc	$ 0.005 (-50.00%)	100k
RFRRenforth Resources Inc	$ 0.01 (-33.33%)	200k
CVGRCity View Green Holdings Inc	$ 0.01 (-33.33%)	880.63k
AICAlphaGen Intelligence Corp	$ 0.015 (-25.00%)	2.1k
WINCommon Stock	$ 0.015 (50.00%)	1.52M
QIMCQuebec Innovative Materials Corp	$ 0.20 (-20.00%)	936.23k
CVGRCity View Green Holdings Inc	$ 0.01 (-33.33%)	880.63k
CULTCult Food Science Corp	$ 0.045 (-10.00%)	570.56k
JOLTJolt Health Inc	$ 0.005 (0.00%)	494.5k

lolroflmao

lolroflmao 3 월 전

PharmAla Reaches Agreement In Principle to Supply MDMA to Clinical Trial in Exchange for Full Data License

https://pharmala.ca/media/2024/11/pharmala-reaches-agreement-in-principle-to-supply-mdma-to-clinical-trial-in-exchange-for-full-data-license

lolroflmao

lolroflmao 3 월 전

News: PharmAla to supply LaNeo MDMA for Clinical Trial at Yale

https://pharmala.ca/media/2024/11/pharmala-to-supply-laneo-mdma-for-clinical-trial-at-yale

lolroflmao

lolroflmao 4 월 전

PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA Press Release | 10/21/2024

https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Mt-Sinai-Hospital-with-LaNeo-MDMA?id=456329

lolroflmao

lolroflmao 4 월 전

PharmAla to supply the University of Texas, San Antonio, with novel dosage form of LaNeo™ MDMA Press Release | 10/08/2024

https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-the-University-of-Texas-San-Antonio-with-novel-dosage-form-of-LaNeo-MDMA?id=455196

lolroflmao

lolroflmao 4 월 전

PharmAla to supply Harvard Medical School’s Maclean Hospital with LaNeo MDMAPress Release | 10/02/2024
https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Harvard-Medical-Schools-Maclean-Hospital-with-LaNeo-MDMA?id=454666

lolroflmao

lolroflmao 4 월 전

PharmAla to supply Johns Hopkins Medicine for Clinical TrialPress Release | 09/11/2024

https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Johns-Hopkins-Medicine-for-Clinical-Trial?id=452770

Dewayne18

Dewayne18 2 년 전

$MDMA New Short Call: Shorts in at 30 cents today. Stay tuned tomorrow for details of its pending doom. Last call 34% in less than 2 days.

Dewayne18

Dewayne18 2 년 전

$MDMA SHORT ALERT!!!

Company up on lousy $50,000 deal.... Shorts in at 38 cents CDN.

Quick 30%

Act Now!!!

Dewayne18

Dewayne18 2 년 전

$MDMA is looking like the perfect short. The SP is racing up and the company only has 700K left with shares doubling up in the past 12 months. Over the past 12 months cash went down by 1.2 million.

Forcealpine

Forcealpine 3 년 전

It looks like this IPO has gone similarly to all psych companies have. The industry needs a massive correction, but that cannot happen until government stop obsessing over vaccines and start promoting alternative solutions to the gigantic mental health crisis ongoing and perpetuating daily while being ignored. MDMA looks promising and I'll be keeping a very close eye on its news and resulting share price.

Pharmala Biotech

Oat Tf 1,5% Mg50 Eur

VIA Pharmaceuticals (CE)

Amundi Index Solutions

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관